Endoscopic ultrasound staging for early esophageal cancer: Are we denying patients neoadjuvant chemo-radiation?

Table 1 Clinicopathologic characteristics n (%)

Characteristics
Mean 64.9 yr (range 40-83)
Gender
Male	114 (82)
Female	25 (18)
Tumor location
Middle 1/3 of esophagus	11 (8)
Lower 1/3 of esophagus and GEJ	128 (92)
Tumor histology
Adenocarcinoma	129 (92.8)
Squamous cell carcinoma	10 (7.2)
Clinical stage
T1N0	110 (79.1)
T2N0	29 (20.9)
Type of esophagectomy
Three-field	2 (1.4)
Transhiatal	26 (18.7)
Ivor-Lewis	111 (79.9)
Adjuvant therapy
Chemotherapy	6 (4.3)
Chemoradiation	3 (2.2)
None	130 (93.5)

Table 2 Comparison of clinical and pathologic staging for cT1N0 and cT2N0 sub-groups

	Clinical stage	Pathologic stage
	cT1N0 110	pTisN0 22	pT1N0 67	pT2-3N0 9	pN+ 12
	cT2N0 29	pTis-1N0 15	pT2N0 6	pT3N0 1	pN+ 7
Total	139	37	73	10	19